ABSTRACT
The Aspirational District Program (ADP) is a unique initiative of Government of India launched in 2018 that aims to reduce inter-district multidimensional inequality. ADP aims to bring the most backward districts to catch up with the rest of the other districts in the country. The program is comprehensive in its scope as it targets the improvement of several key development indicators spanning health and nutrition, education, agriculture and water resources, financial inclusion and skill development and basic infrastructure indicators. Aspirational districts (ADs) are eligible for enhanced funding and priority allocation of various initiatives undertaken by the central and state governments. Our research estimates the causal impact of ADP on the targeted health and nutrition indicators using a combination of propensity score matching and difference-in-differences (PSM-DID). We use the fourth and fifth rounds of National Family Health Survey (NFHS) data collected in 2015-16 and 2019-21 respectively which serve as the pre and post-treatment data for our analysis. Moreover, we take advantage of the transparent mechanism outlined for the identification of ADs under ADP, which we use for propensity score matching for our PSM-DID. While we observe negative impact of ADP on early initiation of breastfeeding, we believe that the impact is confounded with the effects of Covid-19 since part of NFHS-5 data was collected during the pandemic. Therefore, the negative impact of ADP on early initiation of breastfeeding disappears when we only use pre-covid data. Additionally, using pre-covid data we find a reduction in the prevalence of underweight children younger than 5 years by 2 to 4% in ADs as an impact of ADP, which is robust across multiple specification. We do not find evidence of any other positive or negative impact of ADP on any other health and nutrition indicators, which is robust. Future research efforts should be made toward impact evaluation of all the targeted indicators in order to get a comprehensive unbiased evaluation of ADP.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
We would like to admit that we discovered a small typo in our statistical code, which we could figure out during analysis using pre-pandemic data. The results previously presented in our initial manuscript reported ATT from the PSM instead of PSM-DID due to the typo in the code. Therefore, we reran our analysis and have reported the updated results. We find that our results have changed with the fixing of the typo on the statistical code. We sincerely apologize for the oversight in the statistical analysis code and the inconvenience it has caused. It was an unintended mistake. In addition, for the identification of AD, we did not have data for road infrastructure when we initially worked on the manuscript. However, during reviewing our manuscript we found that thai data was released by the concerned ministry, which we included in our analysis. With this additional variable, now we have all variables that were used by ADP to identify ADs. We believe that this further strengthens our matching results before the DID.
1 The mapping of the list of interventions under key programs to the targeted health indicators under ADP have been described in details in the table under the section Implementation for Improving Indicators on pages 44-48 of the Operational Guidelines39
2 The definitions of NFHS outcome variables that we include in our analysis is provided in table S2 in the appendix.
5 Pre-covid or NFHS-5 Phase 1 data was collected between 17 June 2019 to 30 January 2020 https://rchiips.org/nfhs/NFHS-5_FCTS/India.pdf
Data Availability
All data produced in the present study are available upon reasonable request to the authors
